10 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

FirstFit Surgical Kit

FDA 510(k)
FDA Class 2 ·Ear, Nose, Throat

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·August 29, 2025

MONOFILAMENT POLYPECTOMY SNARE

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

RESECT MEDICAL INLINE BI-POLAR RF LINEAR COAGULATION DEVICE

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

PROLIFT-SYSTEM PELVIC ANT FLOOR REPAIR

FDA Adverse Event
Injury ·JOHNSON AND JOHNSON·Product code FTL·September 2, 2011

INTERMATE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - IRVINE·Product code FRN·November 10, 2014

NUCLEUS 24 AUDITORY BRAINSTEM IMPLANT SYSTEM

FDA Adverse Event
Injury ·COCHLEAR LTD .·Product code MCM·July 22, 2013

BD LUER-LOK SYRINGE 60 ML

FDA Adverse Event
Malfunction ·BD MEDICAL (BD WEST) MEDICAL SURGICAL·Product code FMF·March 19, 2021

Model Number L111, ESSENTIO DR SL MRI Pacemaker

FDA Enforcement
Class I ·Ongoing·Boston Scientific Corporation·October 22, 2025

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014